Cigna Healthcare has appointed Dr. Stanley Crittenden as its new Chief Medical Officer, effective March 23. He succeeds Dr. Amy Flaster, who was promoted last year to serve as Chief Medical Officer of the broader Cigna organization, including its Evernorth health services unit. Dr. Crittenden will oversee clinical strategy, program implementation, and care quality initiatives for Cigna’s health benefits division.
Glimpse:
Dr. Stanley Crittenden brings extensive experience from roles at Quantum Health (as Enterprise Chief Medical Officer), Evergreen Nephrology, Anthem, and Humana. In his new position, he will focus on advancing clinical programs, improving care quality, enhancing patient experience, and supporting value-based care efforts. The leadership transition reflects Cigna’s ongoing efforts to strengthen clinical oversight amid rising medical costs and the push for more personalized, cost-effective care delivery.
Cigna Healthcare has appointed Dr. Stanley Crittenden as Chief Medical Officer of its health benefits division, effective March 23. He succeeds Dr. Amy Flaster, who was promoted last year to the role of Chief Medical Officer for the broader Cigna organization, including its Evernorth health services unit.
Dr. Crittenden joins Cigna from Quantum Health, where he served as Enterprise Chief Medical Officer, leading clinical strategy and program development. He previously held leadership positions including Chief Medical Officer at Evergreen Nephrology and medical director roles at Anthem and Humana. His deep experience in managed care, population health, and clinical transformation will be instrumental in shaping Cigna’s clinical programs and advancing care quality.
In his new role, Dr. Crittenden will oversee the implementation of clinical initiatives, help refine medical policy, and support the company’s efforts to deliver personalized and affordable care while navigating rising medical costs. Commenting on the appointment, Dr. Amy Flaster noted that Crittenden’s background in healthcare innovation and building high-performing clinical teams will be valuable as Cigna continues to focus on improving outcomes and member experience.
The leadership change is part of broader executive movements at Cigna. The company recently announced that Chief Operating Officer Brian Evanko will succeed David Cordani as CEO upon Cordani’s planned retirement in July. Despite financial pressures and recent workforce reductions, Cigna reported stronger-than-expected fourth-quarter results, with adjusted revenue up 10% and operational income rising 16% year-over-year.
This appointment underscores Cigna’s continued emphasis on strong clinical leadership as it balances cost management with the delivery of high-quality, value-based care in a challenging insurance environment.
“Dr. Crittenden’s extensive experience in clinical strategy and healthcare innovation will be instrumental as we continue to deliver high-quality, personalized care while addressing the evolving needs of our members.”
By
HB Team
Related News
